WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion


Shares of Global Blood Therapeutics Inc. GBT, +37.18% jumped 9.5% in trading on Friday after The Wall Street Journal reported that Pfizer Inc. PFE, -1.01% is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Therapeutics, which markets a sickle-cell treatment, is attracting takeover interest. The company’s stock is up 79.6% this year, while the broader S&P 500 SPX, -0.27% is down 12.8%.

This article was originally published by Read the original article here.

Previous articleThe Big Move: ‘My brother has done nothing,’ but lays claim to my late father’s home. I’ve lived there since 2016. What should I do?
Next article5 things we’ve learned from earnings season so far: What is inflation’s impact?


Please enter your comment!
Please enter your name here